Current status of carbazole hybrids as anticancer agents
| Autor: | Gang‐Qiang Wang, Hua Guo, Shaofa Sun |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Indoles
Cancer chemotherapy Carbazoles Cancer therapy Antineoplastic Agents Structure-Activity Relationship chemistry.chemical_compound Coumarins Drug Discovery medicine Humans Cell Proliferation Pharmacology Chemistry Carbazole Organic Chemistry Cancer Cell Cycle Checkpoints General Medicine Cell cycle medicine.disease Pyrimidines Cancer cell Cancer research Pyrazoles Cancer cell lines |
| Zdroj: | European Journal of Medicinal Chemistry. 229:113999 |
| ISSN: | 0223-5234 |
| DOI: | 10.1016/j.ejmech.2021.113999 |
| Popis: | The drug resistance and low specificity of current available chemotherapeutics to cancer cells are the main reasons responsible for the failure of cancer chemotherapy and remain dramatic challenges for cancer therapy, creating an urgent need to develop novel anticancer agents. Carbazole nucleus, widely distributed in nature, is a predominant feature of a vast array of biologically active compounds. Carbazole derivatives exhibited potential antiproliferative activity against different cancer cell lines by diverse mechanisms, inclusive of arrest cell cycle and induce apoptosis, and several anticancer agents are carbazole-based compounds. Thus, carbazole derivatives represent a fertile source for discovery of novel anticancer therapeutic agents. Over the past several years, a variety of carbazole hybrids have been developed as potential anticancer agents. The present review focuses on the recent progress, from 2016 until now, in knowledge on anticancer properties, structure-activity relationships and mechanisms of action of carbazole hybrids to provide a basis for development of relevant therapeutic agents. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect